Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Biome Australia Ltd ( (AU:BIO) ) just unveiled an update.
Biome Australia Ltd has announced the cessation of Ilario Faenza as a director, effective May 20, 2025. Faenza held significant interests in the company, including 1,534,796 fully paid ordinary shares as a registered holder and 1,421,809 shares through FDV Investments Pty Ltd, an entity he controls. This change in directorship may impact the company’s governance and strategic direction, potentially affecting stakeholders and market perception.
The most recent analyst rating on (AU:BIO) stock is a Buy with a A$0.85 price target. To see the full list of analyst forecasts on Biome Australia Ltd stock, see the AU:BIO Stock Forecast page.
More about Biome Australia Ltd
Biome Australia Ltd operates in the health and wellness industry, focusing on the development and distribution of natural health products. The company is known for its range of probiotics, supplements, and other wellness products aimed at improving consumer health.
Average Trading Volume: 233,157
Technical Sentiment Signal: Sell
Find detailed analytics on BIO stock on TipRanks’ Stock Analysis page.